Find News

Filter articles

Showing 3481 to 3490 of 3632 results

FDA orders 23andMe to cease PGS sales


The US Food and Drug Administration has told genetics company 23andMe to stop selling its Personal Genome Service product immediately.

Medical company in trade secrets dispute with employee


Medical company Scion Biomedical Inc has launched a lawsuit accusing a senior employee of breaching trade secrets to file a patent for her new start-up company.

IPAB revokes probiotic patent

India26-11-2013Legal developments

The IPAB has revoked US probiotic dietary supplement maker Kibow Biotech’s Indian patent covering a formulation used to increase kidney function.

Teva to lose grip on Copaxone next year

US20-11-2013Legal developments

The US Supreme Court has refused a request from Teva to stay an appeals court order, meaning the pharmaceutical company will lose exclusivity on Copaxone in May next year, rather than in 2015.

Cadence wins Ofirmev patent infringement case

US19-11-2013Legal developments

Cadence Pharmaceuticals announced on November 14 that the US District Court for the District of Delaware ruled in its favour in its patent infringement suit against Exela Pharma Sciences LLC.

CIPA Life Sciences: an update on the UPC


Kevin Mooney, chairman of the drafting committee for the Unified Patent Court (UPC)’s rules of procedure, explained the current state of play to the CIPA Life Sciences conference.

CIPA Life Sciences: How to navigate the EPO boards of appeal


The EPO boards of appeal are unlikely to be able to reduce the case backlog anytime soon, but attorneys should be wary of possible changes in board practice, former board head Alec Clelland told the CIPA Life Sciences conference.

Senate IP counsel set for Covington switch


Aaron Cooper, chief counsel for IP and antitrust law in the US Senate Judiciary Committee, is to join law firm Covington & Burling LLP.

FTC clarifies rules on patent right transfers


The FTC has issued final changes to the premerger notification rules that require pharmaceutical companies to report certain proposed patent right acquisitions to the commission and US Department of Justice for antitrust review.

Biologics milestone as court denies declaratory judgment

US13-11-2013Legal developments

The US District Court for the Northern District of California has dismissed biosimilar maker Sandoz’s motion for declaratory judgment that its etanercept product does not infringe biopharmaceutical company Amgen’s arthritis drug Enbrel.

Showing 3481 to 3490 of 3632 results